Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-02-02 @ 2:36 AM
Study NCT ID:
NCT01725256
Status:
TERMINATED
Last Update Posted:
2014-04-09
First Post:
2012-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Sponsor:
Aires Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Arterial Hypertension | View |